Searched by
MHC Allele - A*02:01
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M219-2 |
HLA-A*02:01 SMARCD3 Neoepitope Tetramer-KLFEFLVYGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLFEFLVYGV | 4°C | |||||
|
TS-M226-1 |
HLA-A*02:01 Astrotactin-1 Neoepitope Tetramer-KLYGLDWAEL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLYGLDWAEL | 4°C | |||||
|
TS-M214-2 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLLGVKLFGV | 4°C | |||||
|
TS-M232-1 |
HLA-A*02:01 MRM1 Neoepitope Tetramer-LLFGMPPCL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFGMPPCL | 4°C | |||||
|
TS-M213-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ACDPHSGHFV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ACDPHSGHFV | 4°C | |||||
|
TS-M242-2 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AMAGSLVFL | 4°C | |||||
|
TS-M224-2 |
HLA-A*02:01 CDC37L1 Neoepitope Tetramer-FLSDHLYLV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLSDHLYLV | 4°C | |||||
|
TS-M213-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ACDPHSGHFV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ACDPHSGHFV | 4°C | |||||
|
TC-8018-1 |
HLA-A*02:01 HBV194-202 Tetramer-FLLTKILTI-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTKILTI | 194-202 | 4°C | ||||
|
TS-M226-2 |
HLA-A*02:01 Astrotactin-1 Neoepitope Tetramer-KLYGLDWAEL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLYGLDWAEL | 4°C | |||||
|
TS-M216-1 |
HLA-A*02:01 HAUS3 Neoepitope Tetramer-ILNAMIAKI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILNAMIAKI | 4°C | |||||
|
TS-M204-2 |
HLA-A*02:01 HCV polyprotein Tetramer-YLLPRRGPRL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLPRRGPRL | 35-44 | 4°C | ||||
|
TS-M218-1 |
HLA-A*02:01 ACTN1 Neoepitpe Tetramer-FIASNGVKLV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FIASNGVKLV | 4°C | |||||
|
TS-M210-1 |
HLA-A*02:01 AHNAK Neoepitope Tetramer-FMPDFDLHL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMPDFDLHL | 4°C | |||||
|
TC-8024-1 |
HLA-A*02:01 KRAS5-14 WT Tetramer-KLVVVGAGGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAGGV | 5-14 | 4°C | ||||
|
TC-8008-2 |
HLA-A*02:01 HPV29-38 Tetramer-TIHDIILECV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| TIHDIILECV | 29-38 | 4°C | ||||
|
TS-M245-2 |
HLA-A*02:01 Sarcospan Neoepitope Tetramer-LMASISSFL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMASISSFL | 4°C | |||||
|
TS-M216-2 |
HLA-A*02:01 HAUS3 Neoepitope Tetramer-ILNAMIAKI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILNAMIAKI | 4°C | |||||
|
TS-M228-1 |
HLA-A*02:01 PGML5 Neoepitope Tetramer-AVGSYVYSV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVGSYVYSV | 4°C | |||||
|
TS-M205-1 |
HLA-A*02:01 HCV polyprotein Tetramer-DLMGYIPLV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| DLMGYIPLV | 132-140 | 4°C | ||||
|
TS-M240-2 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLAI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLAI | 4°C | |||||
|
TS-M210-2 |
HLA-A*02:01 AHNAK Neoepitope Tetramer-FMPDFDLHL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FMPDFDLHL | 4°C | |||||
|
TS-M235-1 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HIAKSLFEV | 4°C | |||||
|
TS-M244-2 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVMSWAPPV | 4°C | |||||
|
TS-M229-2 |
HLA-A*02:01 SNX24 Neoepitope Tetramer-KLSHQLVLL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLSHQLVLL | 4°C | |||||
|
TS-M221-2 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYGFVPVL | 4°C | |||||
|
TS-M227-1 |
HLA-A*02:01 KMT2D Neoepitope Tetramer-ALSPVIPHI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALSPVIPHI | 4°C | |||||
|
TS-M209-1 |
HLA-A*02:01 SRPX Neoepitope Tetramer-TLWCSPIKV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| TLWCSPIKV | 4°C | |||||
|
TS-M249-2 |
HLA-A*02:01 APOL1 Tetramer-ALADGVQKV-APC |
|
|||
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALADGVQKV | 192-200 | 4°C | ||||
|
TS-M223-1 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-VLENFTIFLV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLENFTIFLV | 4°C | |||||
|
TS-M204-1 |
HLA-A*02:01 HCV polyprotein Tetramer-YLLPRRGPRL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLPRRGPRL | 35-44 | 4°C | ||||
|
TS-M217-1 |
HLA-A*02:01 ME3 Neoepitope Tetramer-FLDEFMEGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDEFMEGV | 4°C | |||||
|
TS-M245-1 |
HLA-A*02:01 Sarcospan Neoepitope Tetramer-LMASISSFL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMASISSFL | 4°C | |||||
|
TS-M237-1 |
HLA-A*02:01 GCN1 Neoepitope Tetramer-ALLETPSLLL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLETPSLLL | 4°C | |||||
|
TS-M234-1 |
HLA-A*02:01 GAS7 Neoepitope Tetramer-SLADEAEVYL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLADEAEVYL | 4°C | |||||
|
TS-M205-2 |
HLA-A*02:01 HCV polyprotein Tetramer-DLMGYIPLV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| DLMGYIPLV | 132-140 | 4°C | ||||
|
TS-M250-1 |
HLA-A*02:01 EBV BRLF1 Tetramer-YVLDHLIVV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YVLDHLIVV | 109-117 | 4°C | ||||
|
TC-8011-2 |
HLA-A*02:01 KRAS5-14 G12V Tetramer-KLVVVGAVGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAVGV | 5-14 | 4°C | ||||
|
TS-M203-1 |
HLA-A*02:01 HPV16 E7 Tetramer-LLMGTLGIV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLMGTLGIV | 82-90 | 4°C | ||||
|
TS-M248-1 |
HLA-A*02:01 Insulin Tetramer-ALWGPDPAAA-PE |
|
|||
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWGPDPAAA | 15-24 | 4°C | ||||
|
TC-8009-1 |
HLA-A*02:01 MAGE-A4286-294 Tetramer-KVLEHVVRV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEHVVRV | 286-294 | 4°C | ||||
|
TS-M211-1 |
HLA-A*02:01 HER2 Neoepitope Tetramer-ALIHHNTYL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALIHHNTYL | 4°C | |||||
|
TS-M242-1 |
HLA-A*02:01 MCT2 Neoepitope Tetramer-AMAGSLVFL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| AMAGSLVFL | 4°C | |||||
|
TC-8013-2 |
HLA-A*02:01 KRAS5-14 G12C Tetramer-KLVVVGACGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGACGV | 5-14 | 4°C | ||||
|
TS-M235-2 |
HLA-A*02:01 Filamin-A Neoepitope Tetramer-HIAKSLFEV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HIAKSLFEV | 4°C | |||||
|
TS-M231-1 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | 4°C | |||||
|
TS-M220-1 |
HLA-A*02:01 PRDX5 Neoepitope Tetramer-LLLDDLLVSI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLDDLLVSI | 4°C | |||||
|
TS-M207-1 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDPHSGHFV | 4°C | |||||
|
TS-M222-2 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILTGLNYEV | 4°C | |||||
|
TS-M231-2 |
HLA-A*02:01 GNL3L Neoepitope Tetramer-NLNCCSVPV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| NLNCCSVPV | 4°C | |||||
|
TS-M208-1 |
HLA-A*02:01 p53 Neoepitope Tetramer-VVPCEPPEV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVPCEPPEV | 4°C | |||||
|
TS-M206-2 |
HLA-A*02:01 HCV polyprotein Tetramer-LLFNILGGWV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFNILGGWV | 1807-1816 | 4°C | ||||
|
TS-M225-2 |
HLA-A*02:01 Hsp70 Neoepitope Tetramer-SLFEGIDIYT-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFEGIDIYT | 4°C | |||||
|
TS-M229-1 |
HLA-A*02:01 SNX24 Neoepitope Tetramer-KLSHQLVLL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLSHQLVLL | 4°C | |||||
|
TS-M219-1 |
HLA-A*02:01 SMARCD3 Neoepitope Tetramer-KLFEFLVYGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLFEFLVYGV | 4°C | |||||
|
TS-M238-2 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAALFLGL | 4°C | |||||
|
TS-M249-1 |
HLA-A*02:01 APOL1 Tetramer-ALADGVQKV-PE |
|
|||
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALADGVQKV | 192-200 | 4°C | ||||
|
TC-8008-1 |
HLA-A*02:01 HPV29-38 Tetramer-TIHDIILECV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| TIHDIILECV | 29-38 | 4°C | ||||
|
TS-M236-2 |
HLA-A*02:01 PGM5 Neoepitope Tetramer-QQFAVGSYV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| QQFAVGSYV | 4°C | |||||
|
TS-M223-2 |
HLA-A*02:01 TEF-1 Neoepitope Tetramer-VLENFTIFLV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLENFTIFLV | 4°C | |||||
|
TS-M207-2 |
HLA-A*02:01 CDK4 Neoepitope Tetramer-ALDPHSGHFV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALDPHSGHFV | 4°C | |||||
|
TS-M212-1 |
HLA-A*02:01 CLPP Neoepitope Tetramer-ILDKVLVHL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILDKVLVHL | 4°C | |||||
|
TC-8007-1 |
HLA-A*02:01 P53168-176 Tetramer-HMTEVVRRC-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HMTEVVRRC | 168-176 | 4°C | ||||
|
TS-M218-2 |
HLA-A*02:01 ACTN1 Neoepitpe Tetramer-FIASNGVKLV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FIASNGVKLV | 4°C | |||||
|
TS-M224-1 |
HLA-A*02:01 CDC37L1 Neoepitope Tetramer-FLSDHLYLV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLSDHLYLV | 4°C | |||||
|
TC-8019-1 |
HLA-A*02:01 MAGE-A2112-120 Tetramer-KMVELVHFL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KMVELVHFL | 112-120 | 4°C | ||||
|
TS-M214-1 |
HLA-A*02:01 COL18A1 Neoepitope Tetramer-VLLGVKLFGV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLLGVKLFGV | 4°C | |||||
|
TS-M212-2 |
HLA-A*02:01 CLPP Neoepitope Tetramer-ILDKVLVHL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILDKVLVHL | 4°C | |||||
|
TS-M215-1 |
HLA-A*02:01 WDR46 Neoepitope Tetramer-FLIYLDVSV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLIYLDVSV | 4°C | |||||
|
TC-8018-2 |
HLA-A*02:01 HBV194-202 Tetramer-FLLTKILTI-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTKILTI | 194-202 | 4°C | ||||
|
TS-M227-2 |
HLA-A*02:01 KMT2D Neoepitope Tetramer-ALSPVIPHI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALSPVIPHI | 4°C | |||||
|
TS-M209-2 |
HLA-A*02:01 SRPX Neoepitope Tetramer-TLWCSPIKV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| TLWCSPIKV | 4°C | |||||
|
TS-M228-2 |
HLA-A*02:01 PGML5 Neoepitope Tetramer-AVGSYVYSV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVGSYVYSV | 4°C | |||||
|
TS-M220-2 |
HLA-A*02:01 PRDX5 Neoepitope Tetramer-LLLDDLLVSI-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLDDLLVSI | 4°C | |||||
|
TS-M244-1 |
HLA-A*02:01 FNDC3B Neoepitope Tetramer-VVMSWAPPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VVMSWAPPV | 4°C | |||||
|
TS-M221-1 |
HLA-A*02:01 GANAB Neoepitope Tetramer-ALYGFVPVL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALYGFVPVL | 4°C | |||||
|
TC-8024-2 |
HLA-A*02:01 KRAS5-14 WT Tetramer-KLVVVGAGGV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVVVGAGGV | 5-14 | 4°C | ||||
|
TS-M240-1 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLAI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLAI | 4°C | |||||
|
TS-M238-1 |
HLA-A*02:01 SNAT1 Neoepitope Tetramer-ILAALFLGL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAALFLGL | 4°C | |||||
|
TS-M222-1 |
HLA-A*02:01 NSDHL Neoepitope Tetramer-ILTGLNYEV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILTGLNYEV | 4°C | |||||
|
TS-M241-2 |
HLA-A*02:01 CK1α Neoepitope Tetramer-GLFGDIYLA-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLFGDIYLA | 4°C | |||||
|
TC-8020-2 |
HLA-A*02:01 PSMA663-671 Tetramer-MMNDQLMFL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| MMNDQLMFL | 663-671 | 4°C | ||||
|
TS-M206-1 |
HLA-A*02:01 HCV polyprotein Tetramer-LLFNILGGWV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFNILGGWV | 1807-1816 | 4°C | ||||
|
TS-M236-1 |
HLA-A*02:01 PGM5 Neoepitope Tetramer-QQFAVGSYV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| QQFAVGSYV | 4°C | |||||